NYSE:RAD - Rite Aid Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.82 +0.01 (+0.55 %)
(As of 07/22/2018 04:00 PM ET)
Previous Close$1.82
Today's Range$1.80 - $1.85
52-Week Range$1.38 - $2.80
Volume7.66 million shs
Average Volume17.24 million shs
Market Capitalization$1.94 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.69
Rite Aid logoRite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:RAD
CUSIP76775410
Phone717-761-2633

Debt

Debt-to-Equity Ratio1.75
Current Ratio1.49
Quick Ratio0.85

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$21.53 billion
Price / Sales0.09
Cash Flow$0.5871 per share
Price / Cash3.10
Book Value$1.70 per share
Price / Book1.07

Profitability

EPS (Most Recent Fiscal Year)($0.02)
Net Income$943.47 million
Net Margins5.18%
Return on Equity-2.88%
Return on Assets-0.36%

Miscellaneous

Employees59,000
Outstanding Shares1,066,810,000
Market Cap$1,941.59

Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) released its earnings results on Wednesday, June, 27th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by $0.00. The firm had revenue of $5.39 billion for the quarter, compared to the consensus estimate of $5.32 billion. Rite Aid had a negative return on equity of 2.88% and a net margin of 5.18%. The company's revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.05) EPS. View Rite Aid's Earnings History.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release their next quarterly earnings announcement on Thursday, September, 27th 2018. View Earnings Estimates for Rite Aid.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid issued an update on its FY19 earnings guidance on Wednesday, June, 27th. The company provided earnings per share guidance of $0.02-0.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.04. The company issued revenue guidance of $21.70-22.10 billion, compared to the consensus revenue estimate of $21.65 billion.

What price target have analysts set for RAD?

7 equities research analysts have issued 1 year target prices for Rite Aid's stock. Their predictions range from $1.50 to $2.35. On average, they expect Rite Aid's stock price to reach $2.0143 in the next year. This suggests a possible upside of 10.7% from the stock's current price. View Analyst Ratings for Rite Aid.

What is the consensus analysts' recommendation for Rite Aid?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."

Are investors shorting Rite Aid?

Rite Aid saw a increase in short interest in June. As of June 29th, there was short interest totalling 168,149,070 shares, an increase of 5.9% from the June 15th total of 158,846,719 shares. Based on an average daily trading volume, of 27,494,329 shares, the days-to-cover ratio is presently 6.1 days. Currently, 16.0% of the company's stock are short sold. View Rite Aid's Current Options Chain.

Who are some of Rite Aid's key competitors?

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:
  • Mr. John T. Standley, Chairman & CEO (Age 55)
  • Mr. Kermit Ray Crawford, Pres & COO (Age 59)
  • Mr. Darren Wayne Karst, Sr. Exec. VP, CFO & Chief Admin. Officer (Age 58)
  • Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy (Age 48)
  • Mr. Bryan Everett, Chief Operating Officer of Rite Aid Stores (Age 45)

Has Rite Aid been receiving favorable news coverage?

News headlines about RAD stock have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Rite Aid earned a coverage optimism score of 0.04 on Accern's scale. They also assigned media stories about the company an impact score of 45.72 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Creative Planning (0.05%), Xact Kapitalforvaltning AB (0.02%) and Amalgamated Bank (0.01%). View Institutional Ownership Trends for Rite Aid.

Which institutional investors are selling Rite Aid stock?

RAD stock was sold by a variety of institutional investors in the last quarter, including Creative Planning and Amalgamated Bank. View Insider Buying and Selling for Rite Aid.

Which institutional investors are buying Rite Aid stock?

RAD stock was purchased by a variety of institutional investors in the last quarter, including Xact Kapitalforvaltning AB. View Insider Buying and Selling for Rite Aid.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $1.82.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $1.94 billion and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 59,000 workers across the globe.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]


MarketBeat Community Rating for Rite Aid (NYSE RAD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  409 (Vote Outperform)
Underperform Votes:  410 (Vote Underperform)
Total Votes:  819
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.